A detailed history of Geode Capital Management, LLC transactions in Orgenesis Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 283,077 shares of ORGS stock, worth $339,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
283,077
Previous 287,955 1.69%
Holding current value
$339,692
Previous $236,000 28.39%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$0.39 - $0.63 $1,902 - $3,073
-4,878 Reduced 1.69%
283,077 $169,000
Q1 2024

May 13, 2024

BUY
$0.28 - $0.9 $13,633 - $43,821
48,691 Added 20.35%
287,955 $236,000
Q3 2023

Nov 13, 2023

BUY
$0.41 - $1.4 $13,329 - $45,514
32,510 Added 15.72%
239,264 $148,000
Q4 2022

Feb 13, 2023

BUY
$1.18 - $2.24 $8,493 - $16,123
7,198 Added 3.61%
206,754 $403,000
Q2 2022

Aug 12, 2022

BUY
$1.8 - $3.74 $4,687 - $9,738
2,604 Added 1.32%
199,556 $482,000
Q4 2021

Feb 11, 2022

SELL
$2.61 - $4.9 $26 - $49
-10 Reduced 0.01%
196,952 $567,000
Q3 2021

Nov 12, 2021

BUY
$4.6 - $5.44 $15,419 - $18,234
3,352 Added 1.73%
196,962 $974,000
Q2 2021

Aug 13, 2021

SELL
$4.19 - $5.88 $373,261 - $523,813
-89,084 Reduced 31.51%
193,610 $981,000
Q1 2021

May 12, 2021

BUY
$4.77 - $8.08 $442,322 - $749,258
92,730 Added 48.81%
282,694 $1.62 Million
Q4 2020

Feb 12, 2021

BUY
$4.4 - $5.63 $22,435 - $28,707
5,099 Added 2.76%
189,964 $854,000
Q3 2020

Nov 13, 2020

BUY
$4.75 - $5.99 $21,731 - $27,404
4,575 Added 2.54%
184,865 $931,000
Q2 2020

Aug 13, 2020

BUY
$3.6 - $7.84 $459,867 - $1 Million
127,741 Added 243.09%
180,290 $1.1 Million
Q1 2020

May 14, 2020

BUY
$2.76 - $5.44 $19,662 - $38,754
7,124 Added 15.68%
52,549 $199,000
Q4 2018

Feb 13, 2019

BUY
$3.88 - $7.46 $176,249 - $338,870
45,425 New
45,425 $212,000

Others Institutions Holding ORGS

About Orgenesis Inc.


  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $30.7M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.